Loading organizations...
Vinci Capital is a Swiss private equity firm that, with the Renaissance PME investment foundation, provides equity to privately-held small and medium-sized enterprises. Focusing on technology and industrial sectors, the firm employs an investment team of former high-tech executives, offering strategic support and specialized expertise to portfolio companies.
The Renaissance investment foundation began directing Swiss capital into domestic SMEs in 1998; Vinci Capital formed in 2003 to manage these efforts. This collaboration stemmed from the insight that Swiss pension institutions required structured avenues to invest directly into the nation's private market, fostering growth and ensuring business continuity.
Swiss pension institutions act as key investors, with numerous Swiss SMEs benefiting from their provided growth capital. Vinci Capital and Renaissance PME are committed to strengthening the Swiss economy by supporting the succession and expansion of its small and medium-sized business landscape. Their guiding principle, "Swiss capital for Swiss SMEs," drives long-term domestic stability.
Vinci Capital/Renaissance PME has 2 tracked investments across 2 companies. The latest tracked deal is $18.0M Series C in SENSIMED in October 2012.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Oct 1, 2012 | SENSIMED | $18.0M Series C | Wellington Partners, Agate Medical Investments, Vinci Capital/renaissance PME | ELM Development, Sandoz Family Foundation |
| Dec 15, 2009 | Evolva | $15.3M Series B Extension | — | Aravis, Auriga Partners, Wellington Partners |